Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Chemicals

Rating :
N/A

BSE: 543275 | NSE: ANURAS

733.85
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  714.05
  •  754.00
  •  714.05
  •  715.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  164966
  •  1212.27
  •  966.00
  •  601.30

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,015.82
  • 88.04
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,234.79
  • 0.20%
  • 2.47

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 61.18%
  • 2.34%
  • 26.23%
  • FII
  • DII
  • Others
  • 7.46%
  • 2.06%
  • 0.73%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.28
  • 22.77
  • 11.16

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.30
  • 24.15
  • 4.54

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.43
  • 19.30
  • -5.46

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 60.81

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.76

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 24.54

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
11.89
11.45
19.67
27.05
P/E Ratio
60.93
63.27
36.84
26.78
Revenue
1443
1364
1817
2197
EBITDA
381
351
487
611
Net Income
129
113
219
301
ROA
3.1
5
6.7
8.5
P/Bk Ratio
2.88
2.74
2.52
2.31
ROE
5.01
4.1
6.87
8.73
FCFF
-739.01
341.82
43.63
260.32
FCFF Yield
-8.27
3.83
0.49
2.91

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
390.14
295.52
32.02%
293.96
392.15
-25.04%
254.20
386.39
-34.21%
401.01
479.96
-16.45%
Expenses
265.84
216.44
22.82%
213.55
284.67
-24.98%
201.02
284.98
-29.46%
308.32
362.67
-14.99%
EBITDA
124.30
79.08
57.18%
80.42
107.48
-25.18%
53.18
101.41
-47.56%
92.69
117.29
-20.97%
EBIDTM
31.86%
26.76%
27.36%
27.41%
20.92%
26.25%
23.11%
24.44%
Other Income
-3.55
2.38
-
1.93
3.46
-44.22%
6.07
12.37
-50.93%
12.04
24.26
-50.37%
Interest
31.96
25.13
27.18%
26.66
20.43
30.49%
22.38
17.80
25.73%
26.07
20.26
28.68%
Depreciation
29.29
20.43
43.37%
21.68
19.85
9.22%
20.65
18.68
10.55%
20.74
18.53
11.93%
PBT
59.50
35.90
65.74%
34.02
70.66
-51.85%
16.22
77.30
-79.02%
57.91
102.77
-43.65%
Tax
5.29
9.88
-46.46%
3.40
21.97
-84.52%
4.01
25.05
-83.99%
17.44
30.13
-42.12%
PAT
54.21
26.02
108.34%
30.62
48.69
-37.11%
12.21
52.25
-76.63%
40.47
72.64
-44.29%
PATM
13.89%
8.80%
10.42%
12.42%
4.80%
13.52%
10.09%
15.13%
EPS
2.56
1.68
52.38%
1.52
3.78
-59.79%
0.36
3.59
-89.97%
2.82
5.27
-46.49%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 16
Net Sales
1,339.31
1,475.07
1,601.90
1,073.77
810.89
528.88
287.80
Net Sales Growth
-13.82%
-7.92%
49.18%
32.42%
53.32%
83.77%
 
Cost Of Goods Sold
554.87
614.39
703.56
369.90
338.96
210.53
118.17
Gross Profit
784.44
860.68
898.35
703.87
471.93
318.35
169.62
GP Margin
58.57%
58.35%
56.08%
65.55%
58.20%
60.19%
58.94%
Total Expenditure
988.73
1,094.41
1,170.55
768.96
617.30
399.80
208.18
Power & Fuel Cost
-
1.17
0.77
0.00
0.00
0.00
20.10
% Of Sales
-
0.08%
0.05%
0%
0%
0%
6.98%
Employee Cost
-
75.14
68.90
48.50
32.44
21.09
12.37
% Of Sales
-
5.09%
4.30%
4.52%
4.00%
3.99%
4.30%
Manufacturing Exp.
-
295.92
294.85
288.27
202.75
130.04
10.38
% Of Sales
-
20.06%
18.41%
26.85%
25.00%
24.59%
3.61%
General & Admin Exp.
-
71.72
62.88
38.58
26.03
21.48
12.85
% Of Sales
-
4.86%
3.93%
3.59%
3.21%
4.06%
4.46%
Selling & Distn. Exp.
-
29.53
30.76
19.84
13.05
9.04
2.93
% Of Sales
-
2.00%
1.92%
1.85%
1.61%
1.71%
1.02%
Miscellaneous Exp.
-
6.53
8.82
3.87
4.07
7.62
31.38
% Of Sales
-
0.44%
0.55%
0.36%
0.50%
1.44%
10.90%
EBITDA
350.59
380.66
431.35
304.81
193.59
129.08
79.62
EBITDA Margin
26.18%
25.81%
26.93%
28.39%
23.87%
24.41%
27.67%
Other Income
16.49
30.25
8.57
7.34
26.61
16.56
7.88
Interest
107.07
89.43
62.66
30.83
68.54
45.26
21.26
Depreciation
92.36
79.70
71.08
60.12
51.65
28.71
12.56
PBT
167.65
241.77
306.19
221.20
100.00
71.67
53.68
Tax
30.14
74.33
90.81
69.68
29.71
18.46
11.03
Tax Rate
17.98%
30.74%
29.66%
31.50%
29.71%
25.76%
20.55%
PAT
137.51
128.60
180.85
152.18
70.30
53.21
42.65
PAT before Minority Interest
79.69
167.43
216.85
152.18
70.30
53.21
42.65
Minority Interest
-57.82
-38.83
-36.00
0.00
0.00
0.00
0.00
PAT Margin
10.27%
8.72%
11.29%
14.17%
8.67%
10.06%
14.82%
PAT Growth
-31.11%
-28.89%
18.84%
116.47%
32.12%
24.76%
 
EPS
12.51
11.70
16.46
13.85
6.40
4.84
3.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
2,761.02
2,372.59
1,726.85
1,573.40
593.53
Share Capital
109.79
107.47
100.25
99.92
78.13
Total Reserves
2,556.77
2,254.15
1,622.45
1,472.85
515.41
Non-Current Liabilities
355.80
459.06
568.63
304.00
576.78
Secured Loans
192.22
280.24
360.52
58.01
265.21
Unsecured Loans
5.83
74.79
133.95
189.38
259.53
Long Term Provisions
1.49
1.10
0.00
0.00
0.00
Current Liabilities
1,315.21
810.79
595.07
429.10
499.73
Trade Payables
415.19
322.57
227.78
199.63
130.15
Other Current Liabilities
194.19
231.41
140.45
153.85
119.20
Short Term Borrowings
698.20
235.71
208.08
42.77
237.11
Short Term Provisions
7.63
21.10
18.75
32.85
13.26
Total Liabilities
4,601.66
3,777.92
2,890.55
2,306.50
1,670.04
Net Block
1,501.40
1,417.24
1,202.23
1,115.07
977.34
Gross Block
1,994.18
1,830.37
1,427.24
1,287.12
1,098.03
Accumulated Depreciation
492.78
413.14
225.01
172.06
120.69
Non Current Assets
2,375.05
1,666.73
1,443.92
1,207.54
1,112.53
Capital Work in Progress
609.35
120.34
43.70
43.22
100.95
Non Current Investment
1.45
1.42
148.82
0.02
0.40
Long Term Loans & Adv.
262.13
126.70
44.08
49.22
32.36
Other Non Current Assets
0.72
1.03
5.08
0.01
1.49
Current Assets
2,226.62
2,111.19
1,446.63
1,098.97
557.51
Current Investments
65.17
65.62
0.00
0.00
0.00
Inventories
1,055.33
931.47
863.19
492.22
297.04
Sundry Debtors
579.39
415.08
280.10
205.49
129.49
Cash & Bank
289.26
564.30
209.71
295.71
26.83
Other Current Assets
237.48
23.80
12.17
27.31
104.14
Short Term Loans & Adv.
207.93
110.92
81.46
78.24
89.08
Net Current Assets
911.40
1,300.40
851.56
669.87
57.78
Total Assets
4,601.67
3,777.92
2,890.55
2,306.51
1,670.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
59.03
292.07
-171.23
1.46
94.94
PBT
241.77
307.66
221.20
100.00
71.67
Adjustment
146.58
149.34
84.90
119.65
80.94
Changes in Working Capital
-282.07
-95.67
-441.57
-200.63
-48.44
Cash after chg. in Working capital
106.27
361.34
-135.47
19.02
104.17
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-47.24
-69.27
-35.76
-17.56
-9.23
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-392.11
-522.66
-412.04
-193.08
-178.20
Net Fixed Assets
-571.76
-177.70
-140.45
-130.78
Net Investments
-0.99
-10.28
-148.14
0.40
Others
180.64
-334.68
-123.45
-62.70
Cash from Financing Activity
395.07
370.64
384.36
415.77
101.87
Net Cash Inflow / Outflow
61.99
140.06
-198.91
224.15
18.62
Opening Cash & Equivalents
187.81
47.75
241.17
17.02
-1.60
Closing Cash & Equivalent
249.80
187.81
42.26
241.17
17.02

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 16
Book Value (Rs.)
242.89
219.76
171.85
157.40
113.08
29.45
ROA
4.00%
6.50%
5.86%
3.54%
3.55%
8.86%
ROE
6.66%
10.62%
9.24%
6.58%
10.15%
28.96%
ROCE
9.54%
13.03%
11.27%
10.00%
9.03%
17.59%
Fixed Asset Turnover
0.77
0.98
0.79
0.68
0.56
1.00
Receivable days
123.04
79.20
82.53
75.39
86.30
25.98
Inventory Days
245.81
204.46
230.37
177.63
169.92
90.26
Payable days
219.15
142.76
210.87
177.56
83.14
82.49
Cash Conversion Cycle
149.70
140.90
102.03
75.47
173.07
33.75
Total Debt/Equity
0.38
0.33
0.46
0.25
1.38
1.89
Interest Cover
3.70
5.91
8.20
2.46
2.58
3.53

News Update:


  • Anupam Rasayan signs LoI to supply high-performance specialty chemical product
    14th Feb 2025, 10:59 AM

    The supply of this product will span over next 10 years, with cumulative sales projected to reach $195 million

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.